Current Month 2006
Article Features
  Research Finds Antioxidant Therapies Do Not Interfere with Radiation Treatment
Study Identifies Women with Breast Cancer Most Likely to Benefit from Long-Term Use of Aromotase Inhibitors
Breast Cancer Patients with Disabilities Less Likely to Get Breast-Conserving Surgery
Study Offers Innovative Profile of Enzyme that Aids Tumor Growth
Unique Estrogen Receptor Linked to Metastatic Breast Cancer
New Study Warns Against Linking Ashkenazi Jewish Ethnicity to Breast Cancer Genes
Lymphedema Risk is Greatly Increased with Boost of Radiation to Axillary Nodes
Radiation Heart Dose from MammoSite Compared to IMRT for Left-sided Breast Cancers
Immunohistochemical Assay Predicts Clinical Trial Results for Breast Cancer Patients
Pituitary Hormone May Be Alternative for Hormone Replacement Therapy
Many Newly Diagnosed Breast Cancer Patients Have Unrecognized and Undertreated Psychological Needs
Research Finds Shorter Course of Radiation Treatment Safe for Breast Cancer
Surgical Biopsy May Reveal Cancer in Women with Rare but Benign Breast Condition
Oral Contraceptives Increase Risk for Breast Cancer in Some Women
Younger African-American Women at Higher Risk for Breast Cancer


Order of Chemotherapy, Radiation Has No Effect on Breast Cancer Survival

For women who have had surgery for early breast cancer, it may not matter whether they receive follow-up chemotherapy before, after or during radiation therapy, according to a new review of studies.

A woman's chances of survival or seeing the cancer return are similar in all three cases, if radiation therapy and chemotherapy begin within seven months after surgery, the review concludes.

However, the studies suggest that certain toxic side effects in the blood and esophagus - common in chemotherapy and radiation patients - may be up to 44 percent more likely when the two therapies are delivered at the same time, said Dr. Brigid Hickey and colleagues at the Southern Zone Radiation Oncology Service in Brisbane, Australia.

The reviewers also note that most of the women in the studies were treated about 10 years ago. "As a result, the trials do not assess the modern types of radiotherapy and newer types of chemotherapy" and other anti-cancer drugs such as Herceptin, Hickey said.

Studies show that radiation therapy can reduce the risk of breast cancer returning in the treated breast and boost the likelihood of survival after breast cancer surgery. Doctors may also prescribe chemotherapy to women at high risk for having the cancer spread to other parts of the body after surgery, to reduce the risk of dying from breast cancer.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon